Search Result

Results for "

pak

" in MedChemExpress (MCE) Product Catalog:

By Targets:	PAK (86) Akt (4) Apoptosis (15) Autophagy (3) Bacterial (1) Cadherin (1) CCR (1) Cdc42-binding kinase (1) Endogenous Metabolite (7) ERK (1) FLT3 (1) Fungal (1) HDAC (1) Interleukin Related (1) Isotope-Labeled Compounds (4) Ligands for Target Protein for PROTAC (1) LIM Kinase (LIMK) (3) LPL Receptor (6) MAP3K (1) MEK (1) MMP (1) mTOR (4) NADPH Oxidase (3) NAMPT (1) NF-κB (12) P-selectin (1) Parasite (1) PD-1/PD-L1 (1) PERK (3) PI3K (1) Potassium Channel (1) PPAR (9) PROTACs (2) Ras (6) Reactive Oxygen Species (ROS) (4) Reference Standards (5) ROCK (3) Salt-inducible Kinase (SIK) (2) Small Interfering RNA (siRNA) (19) STAT (1) STK33 (1) Tau Protein (1) TNF Receptor (1) Trk Receptor (1)
By Research Areas:	Cancer (68) Cardiovascular Disease (2) Infection (3) Inflammation/Immunology (17) Metabolic Disease (2) Neurological Disease (5)
Oligonucleotides:	Rat Pre-designed siRNA Sets (6) Mouse Pre-designed siRNA Sets (6) Human Pre-designed siRNA Sets (7) siRNAs (19)

Inhibitors & Agonists

Peptides

Natural
Products

Recombinant Proteins

Isotope-Labeled Compounds

Antibodies

Oligonucleotides

Targets Recommended: PAK

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-10071

Y-27632 Maximum Cited Publications 533 Publications Verification	mTOR Ras ROCK NADPH Oxidase NF-κB Reactive Oxygen Species (ROS) Akt Apoptosis Autophagy PAK	Cancer
Y-27632 is a ROCK inhibitor with K_i values of 220 nM and 300 nM for ROCK1 and ROCK2, respectively. Y-27632 exerts anti-inflammatory and immunomodulatory effects in systemic lupus erythematosus models by inhibiting the ROCK/NF-κB pathway. Y-27632 enhances autophagy by inhibiting the AKT/mTOR pathway, thereby inducing apoptosis apoptosis in oral squamous cell carcinoma. Y-27632 induces the formation of tunneling nanotubes in ARPE-19 cells and significantly enhances mitochondrial transfer through these channels. Y-27632 promotes neurite outgrowth in PC12 cells by activating the *Rac1/NOX1/ROS/AKT/PAK1* signaling cascade .

HY-15027

5-Aminosalicylic Acid 30+ Cited Publications Mesalamine; 5-ASA; Mesalazine	PPAR PAK NF-κB Endogenous Metabolite	Inflammation/Immunology Cancer
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

HY-12005

Fingolimod hydrochloride 75+ Cited Publications FTY720	LPL Receptor PAK	Inflammation/Immunology Cancer
Fingolimod (FTY720) hydrochloride is a sphingosine 1-phosphate (S1P) antagonist with IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod hydrochloride is also a *pak1* activator and immunosuppressant .

HY-11063

Fingolimod 75+ Cited Publications FTY720 free base	LPL Receptor PAK	Infection Neurological Disease Inflammation/Immunology Cancer
Fingolimod (FTY720 free base) is a brain-penetrant sphingosine 1-phosphate (S1P) antagonist with an IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod also is a *pak1* activator, a immunosuppressant .

HY-15663

IPA-3 15+ Cited Publications	PAK	Cancer
IPA-3 is a selective non-ATP competitive *PAK1* inhibitor with IC₅₀ of 2.5 μM, and shows no inhibition to group II PAKs (PAKs 4-6).

HY-100519

*NVS-PAK1-1* 5 Publications Verification	PAK	Cancer
NVS-PAK1-1, a chemical probe, is a potent and selective allosteric *PAK1* inhibitor with an IC₅₀ of 5 nM .

HY-13007

PF-3758309 5+ Cited Publications PF-03758309	PAK Apoptosis	Cancer
PF-3758309 (PF-03758309) is a potent, orally available, and reversible ATP-competitive inhibitor of *PAK4* (K_d= 2.7 nM; K_i=18.7 nM). PF-3758309 has the expected cellular functions of a PAK4 inhibitor: inhibition of anchorage-independent growth, induction of apoptosis, cytoskeletal remodeling, and inhibition of proliferation .

HY-15542B

FRAX486 5+ Cited Publications	PAK	Cancer
FRAX486 is a p21-activated kinase (PAK) inhibitor with IC₅₀s of 14, 33 and 39 nM for PAK1, PAK2 and PAK3, respectively.

HY-12793

Padnarsertib 3 Publications Verification KPT-9274	PAK NAMPT	Cancer
Padnarsertib (KPT-9274) is an orally bioavailable, dual *PAK4/Nicotinamide* phosphoribosyltransferase (Nampt) inhibitor, with IC₅₀s of <100 nM and 120 nM, respectively .

HY-12810

EHop-016 5+ Cited Publications	Ras	Cancer
EHop-016 is a potent and selective Rac GTPase Rac1 and Rac3 inhibitor. EHop-016 inhibits Rac1 activity with an IC₅₀ of 1.1 μM in MDA-MB-435 cells. EHop-016 inhibits Vav2 interaction with Rac, Rac-activated PAK1, lamellipodia formation, and cell migration .

HY-19635

G-5555 5+ Cited Publications	PAK	Cancer
G-5555 is a potent p21-activated kinase 1 (PAK1) inhibitor with K_is of 3.7 nM and 11 nM for PAK1 and PAK2, respectively.

HY-15542A

FRAX597 5+ Cited Publications	PAK	Cancer
FRAX597 is a potent group I p21-activated Kinases (PAKs) inhibitor with IC₅₀ of 8, 13 and 19 nM for *PAK1*, 2 and 3.

HY-12632

GNE 2861 2 Publications Verification	PAK	Cancer
GNE 2861 is a *PAK* inhibitor that displays group II selectivity. GNE 2861 inhibits PAK4, PAK5 and PAK6 with IC₅₀s of 7.5, 36, 126 nM, respectively.

HY-19538

FRAX1036 5 Publications Verification	PAK	Cancer
FRAX1036 is a *PAK* inhibitor with K_is of 23.3 nM, 72.4 nM, and 2.4 μM for PAK1, PAK2 and PAK4, respectively.

HY-120940

AZ13705339	PAK	Cancer
AZ13705339 is a highly potent and selective *PAK1* inhibitor with IC₅₀s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 has binding affinities to PAK1 and PAK2, with K_ds of 0.28 nM and 0.32 nM, respectively. AZ13705339 can be used in the research of cancers .

HY-132828

Odatroltide LT3001; DHDMIQK(KAP)	P-selectin	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Odatroltide (LT3001; DHDMIQK(KAP)) is a P-selectin inhibitor. Odatroltide is a peptide molecule comprising a tripeptide Pro-Ala-Lys (PAK) and an (S)-6,7-dihydroxy-1,1-dimethyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid domain. Odatroltide can restore cerebral blood flow, scavenge free radicals, and inhibit leukocyte migration. Odatroltide possesses thrombolytic and anti-thrombotic activities .

HY-125035

LCH-7749944 5 Publications Verification GNF-PF-2356	PAK Apoptosis	Cancer
LCH-7749944 (GNF-PF-2356) is a potent *PAK4* inhibitor with an IC₅₀ of 14.93 μM. LCH-7749944 effectively suppresses the proliferation of human gastric cancer cells through downregulation of PAK4/c-Src/EGFR/cyclin D1 pathway and induces apoptosis .

HY-114331

DLK-IN-1	MAP3K FLT3 PAK STK33 Trk Receptor	Neurological Disease
DLK-IN-1 (Compound 14) is an orally active, blood-brain barrier-penetrable and selective inhibitor of dual leucine zipper kinase (DLK, MAP3K12) with a K_i value of 3 nM. DLK-IN-1 inhibits Flt3, *PAK4, STK33* and TrkA. DLK-IN-1 reduces p-c-Jun. DLK-IN-1 can be used in Alzheimer's disease research .

HY-143490

PAK4-IN-2	PAK Apoptosis	Cancer
PAK4-IN-2 is a highly potent *PAK4* inhibitor with IC₅₀ value of 2.7 nM. PAK4-IN-2 can arrest MV4-11 cells at G0/G1 phase and induce cell apoptosis. PAK4-IN-2 can be used for researching cancer .

HY-139253

MRIA9	Salt-inducible Kinase (SIK) PAK Apoptosis	Cancer
MRIA9, a chemical probe, is an ATP-competitive, pan Salt-Inducible kinase (SIK) and *PAK2/3* inhibitor, with IC₅₀ values of 516 nM, 180 nM and 127 nM for SIK1, SIK2 and SIK3, respectively .

HY-19635A

G-5555 hydrochloride 5+ Cited Publications	PAK	Cancer
G-5555 hydrochloride is a potent and selective p21-activated kinase 1 (PAK1) inhibitor with a K_i of 3.7 nM.

HY-15027S1

5-Aminosalicylic acid-d3 Mesalamine-d₃; 5-ASA-d₃; Mesalazine-d₃	Isotope-Labeled Compounds Endogenous Metabolite NF-κB PAK PPAR	Inflammation/Immunology Cancer
5-Aminosalicylic acid-d₃ is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-11063R

Fingolimod (Standard) FTY720 free base (Standard)	Reference Standards LPL Receptor PAK	Inflammation/Immunology Cancer
Fingolimod (Standard) is the analytical standard of Fingolimod. This product is intended for research and analytical applications. Fingolimod (FTY720 free base) is a brain-penetrant sphingosine 1-phosphate (S1P) antagonist with an IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod also is a pak1 activator, a immunosuppressant .

HY-N8389

Globulol	Bacterial Fungal PAK Akt STAT PD-1/PD-L1 Apoptosis CCR	Infection Cancer
Globulol is a terpenoid metabolite and Antimicrobial agent. Globulol can be isolated from Alpinia oxyphylla Miq. Globulol binds to PAK4, reduces the expression level of *PAK4* in cancer cells, decreases the phosphorylation of AKT, and downregulates the expressions of STAT3, phosphorylated STAT3, and PD-L1. Globulol promotes the secretion of CCL4 by cancer cells. Globulol reduces the viability and proliferation ability of cancer cells, induces G0/G1 cell cycle arrest and Apoptosis in cancer cells, and inhibits cancer cell migration and the integrity of 3D tumor spheres. Globulol enhances the relevant effects of anti-PD-1 agents in the cancer cell microenvironment. Globulol exhibits anticancer activity against liver cancer. Globulol inhibits the mycelial growth of phytopathogenic fungi and the growth of phytopathogenic bacteria. Globulol can be used in studies related to hepatocellular carcinoma .

HY-171034

PQA-18	Interleukin Related TNF Receptor PAK	Inflammation/Immunology
PQA-18 is a unique *PAK2* inhibitor (IC₅₀: 10 nM). PQA-18 has immunosuppressing effects. PQA-18 suppresses IL2, IL4, IL6, and TNFα. PQA-18 inhibits the population of a subset of regulatory T cells and the immunoglobulin (Ig) production against T cell-dependent antigens as well as alleviates dermatitis in mice .

HY-RS09983

PAK1 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PAK	Others
PAK1 Human Pre-designed siRNA Set A contains three designed siRNAs for PAK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAK1 Human Pre-designed siRNA Set A PAK1 Human Pre-designed siRNA Set A

HY-174247

CPS-021	PROTACs PAK Cadherin	Cancer
CPS-021 is a selective *PAK4* PROTAC degrader with a DC₅₀ of 50 nM. CPS-021 has potent antimigratory and invasive activity and significantly suppresses the invasion and metastasis of tumor cells in A549-luc lung metastasis mice model . Pink: PAK4 ligand (HY-174822); Blue: CRBN ligase ligand (HY-10984); Black: linker

HY-15027R

5-Aminosalicylic Acid (Standard) Mesalamine (Standard); 5-ASA (Standard); Mesalazine (Standard)	Reference Standards PPAR PAK NF-κB Endogenous Metabolite	Inflammation/Immunology Cancer
5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

HY-116269

AZA197	Ras Apoptosis PAK ERK	Cancer
AZA197 is a selective small molecule inhibitor of Cdc42.AZA197 suppresses colon cancer cell proliferation, cell migration, invasion and increases apoptosis by down-regulating the *PAK1* and ERK signaling pathways in vitro. AZA197 reduces tumor growth and significantly increases mouse survival in SW620 tumor xenografts. AZA197 can be used for the study of colon cancer .

HY-143704S

5-Aminosalicylic acid-13C6 hydrochloride Mesalamine-13C6 hydrochloride; 5-ASA-13C6 hydrochloride; Mesalazine-13C6 hydrochloride	PPAR NF-κB PAK	Metabolic Disease
5-Aminosalicylic acid-13C6 hydrochloride?(Mesalamine-13C6 hydrochloride; 5-ASA-13C6 hydrochloride; Mesalazine-13C6 hydrochloride) is the 13C labeled 5-Aminosalicylic Acidhydrochloride. 5-Aminosalicylic acid-13C6 hydrochloride?acts as a PPARγ agonist, and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-10071A

Y-27632 hydrochloride hydrate 395+ Cited Publications	ROCK NF-κB Apoptosis Autophagy Akt mTOR NADPH Oxidase Reactive Oxygen Species (ROS) PAK Ras	Neurological Disease Inflammation/Immunology Cancer
Y-27632 hydrochloride hydrate is a ROCK inhibitor with K_i values of 220 nM and 300 nM for ROCK1 and ROCK2, respectively. Y-27632 hydrochloride hydrate exerts anti-inflammatory and immunomodulatory effects in systemic lupus erythematosus models by inhibiting the ROCK/NF-κB pathway. Y-27632 hydrochloride hydrate enhances autophagy by inhibiting the AKT/mTOR pathway, thereby inducing apoptosis apoptosis in oral squamous cell carcinoma. Y-27632 hydrochloride hydrate induces the formation of tunneling nanotubes in ARPE-19 cells and significantly enhances mitochondrial transfer through these channels. Y-27632 hydrochloride hydrate promotes neurite outgrowth in PC12 cells by activating the *Rac1/NOX1/ROS/AKT/PAK1* signaling cascade .

HY-130628

PAK4-IN-1	PAK	Cancer
PAK4-IN-1 (Compound 19) is a potent, selective, orally active *PAK4* inhibitor with robust anti-tumor efficacy in vivo. PAK4-IN-1 is stable under both acidic and neutral conditions .

HY-RS09987

PAK2 Human Pre-designed siRNA Set A	Small Interfering RNA (siRNA) PAK	Others
PAK2 Human Pre-designed siRNA Set A contains three designed siRNAs for PAK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

PAK2 Human Pre-designed siRNA Set A PAK2 Human Pre-designed siRNA Set A

HY-131265

Mesalamine impurity P	PPAR PAK NF-κB	Inflammation/Immunology Cancer
Mesalamine impurity P is an impurity of Mesalamine (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-15027S

5-Aminosalicylic Acid-d3 hydrochloride Mesalamine-D3 hydrochloride; 5-ASA-D3 hydrochloride; Mesalazine-D3 hydrochloride	Isotope-Labeled Compounds PPAR PAK NF-κB Endogenous Metabolite	Inflammation/Immunology Cancer
5-Aminosalicylic Acid-d₃ (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.

HY-11063S

Fingolimod-d4 FTY720 free based-d₄	LPL Receptor PAK	Inflammation/Immunology Cancer
Fingolimod-d₄ is the deuterium labeled Fingolimod. Fingolimod (FTY720 free base) is a brain-penetrant sphingosine 1-phosphate (S1P) antagonist with an IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod also is a pak1 activator, a immunosuppressant .

HY-172545

AMG28	Tau Protein	Neurological Disease
AMG28 is an ATP-competitive inhibitor targeting TTBK1 and TTBK2, with IC₅₀ values of 805 nM and 988 nM, respectively. AMG28 inhibits the phosphorylation of tau protein at the Ser422 site .

HY-176539

PAK1-IN-2	PAK PERK	Cancer
PAK1-IN-2 (Compound 35) is a selective *PAK1* inhibitor with a K_i of 7.3 nM. PAK1-IN-2 can inhibit MEK phosphorylation. PAK1-IN-2 has significant inhibitory effects on PAK1/4 amplified cancer cell lines. PAK1-IN-2 can be used in the study of cancer .

HY-146681

PAK1-IN-1	PAK	Cancer
PAK1-IN-1 is a potent and selective *PAK1* inhibitor with an IC₅₀ of 9.8 nM. PAK1-IN-1 inhibits the migration and invasion of PAK1-related tumour cells in a dose-dependent manner .

HY-159897

PAK4-IN-5	PAK LIM Kinase (LIMK) Apoptosis Reactive Oxygen Species (ROS)	Cancer
PAK4-IN-5 (Compound 12i) is a *PAK4* inhibitor (IC₅₀: 7.68 nM for PAK4, 1872.01 nM for PAK1). PAK4-IN-5 binds to PAK4 stably via multiple interactions. PAK4-IN-5 inhibits the proliferation and the migratory potential of MDA-MB-231 cells by inhibiting the phosphorylation of PAK4 and LIMK1. PAK4-IN-5 arrests cell cycle in the G0/G1 phase, induces apoptosis and ROS production. LD₅₀: >500 mg/kg for mice (p.o.) .

HY-174822

PAK4-IN-6	Ligands for Target Protein for PROTAC PAK	Others
PAK4-IN-6 is a selective degrader of *PAK4. PAK4-IN-6 can be used to synthesize PROTACs* such as CPS-021 (HY-174247) .

HY-131043

*NVS-PAK1-C* 1 Publications Verification	PAK	Cancer
NVS-PAK1-C is a potent, ATP-competitive and specific allosteric *PAK1* inhibitor probe with IC₅₀ values of 5 nM and 6 nM for dephosphorylated PAK1 and phosphorylated PAK1, respectively. NVS-PAK1-C is also against dephosphorylated PAK2 (IC₅₀=270 nM) and phosphorylated PAK2 (IC₅₀=720 nM) .

HY-P10106

*TAT-PAK18 inhibitory peptide*	PAK	Cancer
TAT-PAK18 inhibitory peptide is a membrane-permeable *PAK* inhibitory peptide. TAT-PAK18 inhibitory peptide reduces F-actin clusters and occludes the effect of Shank3 knockdown .

HY-146786

ZMF-10	PAK Apoptosis	Cancer
ZMF-10 is a highly potent *PAK1* inhibitor, with IC₅₀s of 174 nM, 1.038 μM and 1.372 μM for PAK1, PAK2 and PAK3, respectively. ZMF-10 can inhibit PAK1 activity to affect PAK1-regulated apoptosis, ER-Stress and migration in MDA-MB-231 cells. ZMF-10 can be used for researching anticancer .

HY-116917

G-9791	PAK	Cancer
G-9791, a poyridone side chain analogue, is a potent PAK inhibitor with K_i values of 0.95 nM and 2.0 nM for PAK1 and PAK2, respectively .

HY-120940A

AZ13705339 hemihydrate	PAK	Cancer
AZ13705339 hemihydrate is a highly potent and selective *PAK1* inhibitor with IC₅₀s of 0.33 nM and 59 nM for PAK1 and pPAK1, respectively. AZ13705339 hemihydrate has binding affinities to PAK1 and PAK2, with K_ds of 0.28 nM and 0.32 nM, respectively. AZ13705339 hemihydrate can be used in the research of cancers .

HY-15663R

IPA-3 (Standard)	PAK	Cancer
IPA-3 (Standard) is the analytical standard of IPA-3. This product is intended for research and analytical applications. IPA-3 is a selective non-ATP competitive PAK1 inhibitor with IC50 of 2.5 μM, and shows no inhibition to group II PAKs (PAKs 4-6).

HY-117218

KY-04045	PAK	Cancer
KY-04045 is a *PAK4* specific inhibitor (IC₅₀=8.7 μM) that can be used for the development of anticancer drugs targeting *PAK4* .

HY-124398

GL-1196	PAK	Cancer
GL-1196 is an inhibitor of *PAK4. GL-1196 can suppress the proliferation and invasion of gastric cancer cells. GL-1196 inhibits PAK4-mediated signaling pathways. GL-1196 can hinder the proliferation of human gastric cancer cells through suppressing PAK4/c-Src/EGFR/CyclinD1* and CDK4/6. GL-1196 can reduce filamentous pseudopodia formation and induce filamentous pseudopodia formation and promote cell elongation in SGC7901 and BGC823 cells. GL-1196 can be studied in anti-cancer research .

HY-119216

AZ13711265	PAK	Cancer
AZ13711265 is an orally active *PAK1* inhibitor with high selectivity. AZ13711265 has IC₅₀ values of 0.58 nM and 0.11 µM for *PAK1* and pPAK1, respectively. AZ13711265 has low lipophilicity and low clearance, and can be used as an in vivo probe compound for *PAK1*. AZ13711265 can be used in the study of cancer .

Cat. No.	Product Name	Target	Research Area

HY-132828

Odatroltide LT3001; DHDMIQK(KAP)	P-selectin	Cardiovascular Disease Metabolic Disease Inflammation/Immunology
Odatroltide (LT3001; DHDMIQK(KAP)) is a P-selectin inhibitor. Odatroltide is a peptide molecule comprising a tripeptide Pro-Ala-Lys (PAK) and an (S)-6,7-dihydroxy-1,1-dimethyl-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid domain. Odatroltide can restore cerebral blood flow, scavenge free radicals, and inhibit leukocyte migration. Odatroltide possesses thrombolytic and anti-thrombotic activities .

HY-P10106

*TAT-PAK18 inhibitory peptide*	PAK	Cancer
TAT-PAK18 inhibitory peptide is a membrane-permeable *PAK* inhibitory peptide. TAT-PAK18 inhibitory peptide reduces F-actin clusters and occludes the effect of Shank3 knockdown .

HY-P10107

*TAT-PAK18 R192A*	Ras	Others
TAT-PAK18 R192A is an inactive Tat-Pak peptide. TAT-PAK18 R192A does not have any effect in the translocation of Rac1 triggered by any of the interrogated proteins .

Cat. No.	Product Name	Category	Target	Chemical Structure

HY-15027

5-Aminosalicylic Acid 30+ Cited Publications Mesalamine; 5-ASA; Mesalazine	Structural Classification Monophenols Classification of Application Fields Ketones, Aldehydes, Acids Phenols Endogenous metabolite Disease Research Fields Source Classification Cancer	PPAR PAK NF-κB Endogenous Metabolite
5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

HY-N8389

Globulol	Structural Classification Terpenoids Sesquiterpenes Myrtaceae Plants Eucalyptus globulus Labill. Source Classification	Bacterial Fungal PAK Akt STAT PD-1/PD-L1 Apoptosis CCR
Globulol is a terpenoid metabolite and Antimicrobial agent. Globulol can be isolated from Alpinia oxyphylla Miq. Globulol binds to PAK4, reduces the expression level of *PAK4* in cancer cells, decreases the phosphorylation of AKT, and downregulates the expressions of STAT3, phosphorylated STAT3, and PD-L1. Globulol promotes the secretion of CCL4 by cancer cells. Globulol reduces the viability and proliferation ability of cancer cells, induces G0/G1 cell cycle arrest and Apoptosis in cancer cells, and inhibits cancer cell migration and the integrity of 3D tumor spheres. Globulol enhances the relevant effects of anti-PD-1 agents in the cancer cell microenvironment. Globulol exhibits anticancer activity against liver cancer. Globulol inhibits the mycelial growth of phytopathogenic fungi and the growth of phytopathogenic bacteria. Globulol can be used in studies related to hepatocellular carcinoma .

HY-15027R

5-Aminosalicylic Acid (Standard) Mesalamine (Standard); 5-ASA (Standard); Mesalazine (Standard)	Structural Classification Monophenols Ketones, Aldehydes, Acids Phenols Endogenous metabolite Source Classification	Reference Standards PPAR PAK NF-κB Endogenous Metabolite
5-Aminosalicylic Acid (Standard) is the analytical standard of 5-Aminosalicylic Acid. This product is intended for research and analytical applications. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

Species:	Human (15)
Tag:	SUMO (2) His (9) Strep (1) Tag Free (3) Avi (1) GST (4) Flag (1)
Source:	sf9 insect cells (2) Sf9 insect cells (6) E. coli (7)

Cat. No.	Compare	Product Name	Species	Source	Image

HY-P701732

	PAK6 Protein, Human pak6; Serine/threonine-protein kinase pak 6; pak-5; p21-activated kinase 6; pak-6	Human	E. coli
	PAK6, a dynamic serine/threonine kinase, regulates gene transcription activated by AR or MAP2K6/MAPKK6. It phosphorylates and inhibits AR-mediated transcription, hindering ESR1-mediated transcription. PAK6 interacts with IQGAP1, suggesting a role in cytoskeleton regulation. Moreover, it protects cells from apoptosis by phosphorylating BAD, showcasing its multifaceted impact on transcriptional control and cytoskeletal dynamics. PAK6 Protein, Human is the recombinant human-derived PAK6 protein, expressed by E. coli , with tag free.

HY-P701733

	PAK6 Protein, Human (Active, His) pak6; Serine/threonine-protein kinase pak 6; pak-5; p21-activated kinase 6; pak-6	Human	E. coli
	PAK6, a dynamic serine/threonine kinase, regulates gene transcription activated by AR or MAP2K6/MAPKK6. It phosphorylates and inhibits AR-mediated transcription, hindering ESR1-mediated transcription. PAK6 interacts with IQGAP1, suggesting a role in cytoskeleton regulation. Moreover, it protects cells from apoptosis by phosphorylating BAD, showcasing its multifaceted impact on transcriptional control and cytoskeletal dynamics. PAK6 Protein, Human (His) is the recombinant human-derived PAK6 protein, expressed by E. coli , with N-6*His labeled tag.

HY-P72065

	PAK5 Protein, Human (sf9, His) erine/threonine-protein kinase pak 5; pak5	Human	Sf9 insect cells
	PAK5 is a dynamic serine/threonine kinase that affects cytoskeletal regulation, cell migration, proliferation, and survival through multiple pathways. Activation triggers autophosphorylation, affecting RAF1 kinase activity and promoting cell survival through BAD phosphorylation. PAK5 Protein, Human (sf9, His) is the recombinant human-derived PAK5 protein, expressed by sf9 insect cells , with N-6*His labeled tag.

HY-P71530

	PAK1 Protein, Human (His-SUMO) Serine/threonine-protein kinase pak 1; Alpha-pak; p21-activated kinase 1 ; p65-pak; pak1	Human	E. coli
	PAK1 is a dynamic protein kinase that plays an important role in multiple intracellular signaling pathways, affecting cytoskeletal dynamics, adhesion, migration, proliferation, apoptosis, mitosis, and vesicle trafficking. Multifunctional PAK1 directly phosphorylates BAD to provide antiapoptotic cell protection. PAK1 Protein, Human (His-SUMO) is the recombinant human-derived PAK1 protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

HY-P74654

	PAK3 Protein, Human (Active, sf9, His) Serine/threonine-protein kinase pak 3; Beta-pak; Oligophrenin-3; OPHN3	Human	Sf9 insect cells
	PAK3 is a serine/threonine kinase that plays a key role in multiple signaling pathways, affecting cytoskeletal dynamics, cell migration, and cell cycle. Its involvement in dendritic spine morphogenesis and synapse formation emphasizes its importance in neuronal processes. PAK3 Protein, Human (sf9, His) is the recombinant human-derived PAK3 protein, expressed by Sf9 insect cells , with C-His labeled tag.

HY-P705560

	PAK4 Protein, Human (GST) Serine/threonine-protein kinase pak 4; p21-activated kinase 4; KIAA1142; pak-4; EC:2.7.11.1	Human	E. coli

HY-P702745

	PAK2 Protein, Human (sf9, GST) pak2; p21 (RAC1) activated kinase 2; KNO2; pak65; pakgamma	Human	Sf9 insect cells
	PAK2 Protein, Human (sf9, GST) is the recombinant human-derived PAK2, expressed by Sf9 insect cells , with GST labeled tag. ,

HY-P700575

	PAK4 Protein, Human (His-SUMO) p21-activated kinase 4 ; pak-4	Human	E. coli
	PAK4 is an important serine/threonine kinase that affects cytoskeletal regulation, cell migration, growth, and survival through multiple pathways. Activation triggered by various effectors induces autophosphorylation, targeting proteins such as SSH1 and LIMK1 to regulate cofilin activity and stabilize actin filaments. PAK4 Protein, Human (His-SUMO) is the recombinant human-derived PAK4 protein, expressed by E. coli , with N-SUMO, N-6*His labeled tag.

HY-P702746

	PAK3 Protein, Human (sf9) pak3; p21 protein (Cdc42/Rac)-activated kinase 3; bpak; MRX30; MRX47; OPHN3; hpak3; CDKN1A; pak3beta; p21-activated kinase 3; beta-pak; oligophrenin-3; OTTHUMP00000023856; p21 (CDKN1A)-activated kinase 3; serine/threonine-protein kinase pak 3; EC 2.7.11.1	Human	Sf9 insect cells
	PAK3 is a serine/threonine kinase that plays a key role in multiple signaling pathways, affecting cytoskeletal dynamics, cell migration, and cell cycle. Its involvement in dendritic spine morphogenesis and synapse formation emphasizes its importance in neuronal processes. PAK3 Protein, Human (sf9) is the recombinant human-derived PAK3, expressed by Sf9 insect cells, with tag-free.

HY-P705853

	PAK3 Protein, Human (Active, sf9, GST) pak3; p21 protein (Cdc42/Rac)-activated kinase 3; bpak; MRX30; MRX47; OPHN3; hpak3; CDKN1A; pak3beta; p21-activated kinase 3; beta-pak; oligophrenin-3; OTTHUMP00000023856; p21 (CDKN1A)-activated kinase 3; serine/threonine-protein kinase pak 3; EC 2.7.11.1	Human	sf9 insect cells

HY-P702649

	PKN2 Protein, Human (Active, sf9, His, GST) PKN2; protein kinase N2; PRKCL2, protein kinase C like 2; serine/threonine-protein kinase N2; cardiolipin activated protein kinase pak2; pak 2; PRK2; PKN gamma; protein kinase C-like 2; protein-kinase C-related kinase 2; cardiolipin-activated protein kinase pak2; pak2; pak-2; PRKCL2; PRO2042; MGC71074; MGC150606	Human	Sf9 insect cells
	PKN2 Protein, Human (sf9, His, GST) is the recombinant human-derived PKN2, expressed by Sf9 insect cells , with His, GST labeled tag. ,

HY-P702747

	PAK4 Protein, Human (Active, His) pak4; p21 protein (Cdc42/Rac)-activated kinase 4; p21(CDKN1A) activated kinase 4; serine/threonine-protein kinase pak 4; pak-4; p21-activated kinase 4; p21(CDKN1A)-activated kinase 4; protein kinase related to S. cerevisiae STE20, effector for Cdc42Hs	Human	E. coli
	PAK4 is an important serine/threonine kinase that affects cytoskeletal regulation, cell migration, growth, and survival through multiple pathways. Activation triggered by various effectors induces autophosphorylation, targeting proteins such as SSH1 and LIMK1 to regulate cofilin activity and stabilize actin filaments. PAK4 Protein, Human (His) is the recombinant human-derived PAK4, expressed by E. coli, with N-His labeled tag.

HY-P703253

	ARHGEF7 Protein, Human (His, Strep) COOL1; KIAA0142; P85SPR; pak3BP; PIXB	Human	E. coli
	ARHGEF7 Protein, Human (His, Strep) is the recombinant human-derived ARHGEF7, expressed by E. coli, with Strep, His labeled tag.

HY-P705857

	PKN1 Protein, Human (Active, sf9) PKN1; protein kinase N1; PRKCL1, protein kinase C like 1; serine/threonine-protein kinase N1; DBK; MGC46204; pak1; PKN; PRK1; protein kinase C-like 1; protein kinase PKN-alpha; protein kinase C-like PKN; serine-threonine kinase N; protease-activated kinase 1; protein kinase C-related kinase 1; protein-kinase C-related kinase 1; serine-threonine protein kinase N; serine/threonine protein kinase N; pak-1; PRKCL1; PKN-ALPHA	Human	sf9 insect cells

HY-P702648

	PKN1 Protein, Human (sf9, His, Flag) PKN1; protein kinase N1; PRKCL1, protein kinase C like 1; serine/threonine-protein kinase N1; DBK; MGC46204; pak1; PKN; PRK1; protein kinase C-like 1; protein kinase PKN-alpha; protein kinase C-like PKN; serine-threonine kinase N; protease-activated kinase 1; protein kinase C-related kinase 1; protein-kinase C-related kinase 1; serine-threonine protein kinase N; serine/threonine protein kinase N; pak-1; PRKCL1; PKN-ALPHA	Human	Sf9 insect cells
	PKN1 Protein, Human (sf9, His, Flag) is the recombinant human-derived PKN1, expressed by Sf9 insect cells , with His, Flag labeled tag. ,

Compare Products


Products	In-stock - + Add to Cart
Cat. No.
Species
Source
Tag
Accession
Gene ID
Molecular Weight
Purity
Endotoxin Level
Biological Activity
Appearance
Formulation
Storage & Stability
Shipping
Free Sample	Yes No
Size	* This product has been "discontinued". Optimized version of product available: / In-stock - + Add to Cart Get quote

Cat. No.	Product Name	Chemical Structure

HY-15027S1

5-Aminosalicylic acid-d3
5-Aminosalicylic acid-d₃ is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-143704S

5-Aminosalicylic acid-13C6 hydrochloride
5-Aminosalicylic acid-13C6 hydrochloride?(Mesalamine-13C6 hydrochloride; 5-ASA-13C6 hydrochloride; Mesalazine-13C6 hydrochloride) is the 13C labeled 5-Aminosalicylic Acidhydrochloride. 5-Aminosalicylic acid-13C6 hydrochloride?acts as a PPARγ agonist, and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-15027S

5-Aminosalicylic Acid-d3 hydrochloride
5-Aminosalicylic Acid-d₃ (hydrochloride) is the deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) hydrochloride acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.

HY-11063S

Fingolimod-d4
Fingolimod-d₄ is the deuterium labeled Fingolimod. Fingolimod (FTY720 free base) is a brain-penetrant sphingosine 1-phosphate (S1P) antagonist with an IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod also is a pak1 activator, a immunosuppressant .

HY-15027S4

5-Aminosalicylic acid-d7
5-Aminosalicylic acid-d₇ (5-ASA-d₇; Mesalamie-d₇; Mesalazie-d₇) is deuterium labeled 5-Aminosalicylic Acid. 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB. 5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN) .

HY-11063S1

Fingolimod-d4 hydrochloride
Fingolimod-d₄ (hydrochloride) is the deuterium labeled Fingolimod hydrochloride. Fingolimod hydrochloride (FTY720) is a brain-penetrant sphingosine 1-phosphate (S1P) antagonist with an IC₅₀ of 0.033 nM in K562 and NK cells. Fingolimod hydrochloride (FTY720) also is a pak1 activator, a immunosuppressant .

HY-15027S2

5-Aminosalicylic acid-13C6
5-Aminosalicylic acid- ¹³C₆ is the ¹³C labeled 5-Aminosalicylic Acid . 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB .

HY-15027S3

5-Aminosalicylic acid-d3 disodium
5-Aminosalicylic acid-d₃ disodium is deuterated labeled 5-Aminosalicylic Acid (HY-15027). 5-Aminosalicylic acid (Mesalamine) acts as a specific PPARγ agonist and also inhibits p21-activated kinase 1 (PAK1) and NF-κB.5-Aminosalicylic acid can inhibit the activity of osteopontin (OPN).

Host:	Mouse (9) Rabbit (12)
Reactivity:	Human (18) Rat (12) Mouse (10) Monkey (6) human (1)
Application:	IHC-P (12) ICC/IF (11) IF-Tissue (2) IP (6) IHC-F (5) WB (19) FC (7) ELISA (8)
Isotype:	IgG (12) IgG1 (6) IgG2a (1) IgG2b (2)
Conjugation:	Non-conjugated (21)
Clonality:	Monoclonal (12) Monoclonal Antibody (1) Recombinant (8)
Modification:	Phosphorylated (4) Unmodified (10)

Cat. No.	Compare	Product Name	Application	Reactivity	Image

HY-P81618

	PAK1 Antibody (YA1363) 1 Publications Verification pak1; Serine/threonine-protein kinase pak 1; Alpha-pak; p21-activated kinase 1; pak-1; p65-pak	WB, IHC-P, ICC/IF, IP, FC	Human, Mouse, Rat
	PAK1 Antibody (YA1363) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PAK1.

HY-P86446

	PAK1 Antibody (YA6138) pak1; Serine/threonine-protein kinase pak 1; Alpha-pak; p21-activated kinase 1; pak-1; p65-pak	WB, IHC-P, ICC/IF, IP, ELISA	Human, Mouse, Rat
	PAK1 Antibody (YA6138) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PAK1.

HY-P80778

	PAK2 Antibody (YA695) pak2; Serine/threonine-protein kinase pak 2; Gamma-pak; pak65; S6/H4 kinase; p21-activated kinase 2; pak-2; p58	WB, IHC-F, IHC-P, ICC/IF	Human, Monkey
	PAK2 Antibody (YA695) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PAK2.

HY-P85312

	PAK2 Antibody (YA5004) pak2; Serine/threonine-protein kinase pak 2; Gamma-pak; pak65; S6/H4 kinase; p21-activated kinase 2; pak-2; p58	WB, IHC-P, IHC-F, ICC/IF, IF-Tissue, FC	Human, Mouse, Rat
	PAK2 Antibody (YA5004) is a Rabbit-derived and non-conjugated monoclonal antibody, targeting to PAK2.

HY-P81622

	PAK3 Antibody (YA1367) pak3; OPHN3; Serine/threonine-protein kinase pak 3; Beta-pak; Oligophrenin-3; p21-activated kinase 3; pak-3	WB, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	PAK3 Antibody (YA1367) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PAK3.

HY-P80778A

	PAK2 Antibody (YA695)(PBS only) pak2; Serine/threonine-protein kinase pak 2; Gamma-pak; pak65; S6/H4 kinase; p21-activated kinase 2; pak-2; p58	WB, IHC-F, IHC-P, ICC/IF	Human, Monkey
	PAK2 Antibody (YA695) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PAK2.

HY-P83588

	*Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333)* pak4; pak5; pak6	WB	Human, Mouse, Rat
	Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-PAK4/5/6 (Ser474/Ser560/Ser602).

HY-P83870

	PAK3 Antibody (YA3567) ARA; bpak; MRX30; MRX47; OPHN3; pak-3; pak3beta; beta-pak	WB, ELISA	Human, Monkey
	PAK3 Antibody (YA3567) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PAK3.

HY-P83588A

	*Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333)(PBS only)* pak4; pak5; pak6	WB	Human, Mouse, Rat
	Phospho-PAK4/5/6 (Ser474/Ser560/Ser602) Antibody (YA3333) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-PAK4/5/6 (Ser474/Ser560/Ser602).

HY-P83870A

	PAK3 Antibody (YA3567)(PBS only) ARA; bpak; MRX30; MRX47; OPHN3; pak-3; pak3beta; beta-pak	WB, ELISA	Human, Monkey
	PAK3 Antibody (YA3567) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PAK3.

HY-P81785

	*Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530)* pak3; OPHN3; Serine/threonine-protein kinase pak 3; Beta-pak; Oligophrenin-3; p21-activated kinase 3; pak-3	WB, IHC-F, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-PAK1/2/3 (Ser144/Ser141/Ser154).

HY-P81785A

	*Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530)(PBS only)* pak3; OPHN3; Serine/threonine-protein kinase pak 3; Beta-pak; Oligophrenin-3; p21-activated kinase 3; pak-3	WB, IHC-F, IHC-P, ICC/IF, IP	Human, Mouse, Rat
	Phospho-PAK1/2/3 (Ser144/Ser141/Ser154) Antibody (YA1530) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-PAK1/2/3 (Ser144/Ser141/Ser154).

HY-P87028

	*Phospho-PAK4+PAK5+PAK6 (S474 + S560 + S602) Antibody (YA6721)* KIAA1142 antibody; p21 activated kinase 4 antibody; p21 Cdc42/Rac1-actiated kinase 4 antibody; P21 protein (Cdc42/Rac) activated kinase 4 antibody; p21(CDKN1A) activated kinase 4 antibody; p21-activated kinase 4 antibody; pak 4 antibody; pak-4 antibody; pak4 antibody; pak4_HUMAN antibody; KIAA1142 antibody; p21 activated kinase 4 antibody; p21 Cdc42/Rac1-actiated kinase 4 antibody; P21 protein (Cdc42/Rac) activated kinase 4 antibody; p21(CDKN1A) activated kinase 4 antibody; p21-activated kinase 4 antibody; pak 4 antibody; pak-4 antibody; pak4 antibody; pak4_HUMAN antibody; Protein kinase related to S.cerevisiae STE20 effector for Cdc42Hs antibody; Serine threonine kinase pak 4 antibody; Serine/threonine protein kinase pak 4 antibody; Serine/threonine protein kinase pak4 antibody; Serine/threonine-protein kinase pak 4 antibody; EC 2.7.11.1 antibody; KIAA1264 antibody; MGC26232 antibody; p21 activated kinase 7 antibody; p21 protein (Cdc42/Rac)-activated kinase 7 antibody; p21(CDKN1A) activated kinase 7 antibody; p21-activated kinase 5 antibody; p21-activated kinase 7 antibody; pak 5 antibody; pak 7 antibody; pak-5 antibody; pak-7 antibody; pak5 antibody; pak7 antibody; pak7_HUMAN antibody; Protein kinase pak5 antibody; Serine/threonine protein kinase pak 7 antibody; Serine/threonine-protein kinase pak 7 antibody; CDKN1A activated kinase 6 antibody; EC 2.7.1.37 antibody; p21 activated protein kinase 6 antibody; p21 protein (Cdc42/Rac)-activated kinase 6 antibody; p21(CDKN1A) activated kinase 6 antibody; p21-activated kinase 6 antibody; p21activated kinase 6 antibody; pak 6 antibody; pak-6 antibody; pak6 antibody; pak6_HUMAN antibody; Serine threonine protein kinase pak 6 antibody; Serine/threonine protein kinase pak 6 antibody; Serine/threonine protein kinase pak6 antibody; Serine/threonine-protein kinase pak 6 antibody;	WB	Human
	Phospho-PAK4+PAK5+PAK6 (S474 + S560 + S602) Antibody (YA6721) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to Phospho-PAK4+PAK5+PAK6 (S474 + S560 + S602).

HY-P89806

	PAK6 Antibody (YA9150)	WB, ICC/IF, IF-Tissue, IP, ELISA	human
	PAK6 Antibody (YA9150) is a Mouse-derived and non-conjugated IgG2a monoclonal antibody, targeting to PAK6.

HY-P84611

	PKN1 Antibody (YA4308) DBK; PKN; pak1; PRK1; pak-1; PRKCL1; PKN-ALPHA	IHC-P, ICC/IF, FC, ELISA	Human
	PKN1 Antibody (YA4308) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PKN1.

HY-P81919

	PKN1 Antibody (YA1664) DBK; PKN; pak1; PRK1; pak-1; PRKCL1; PKN-ALPHA	WB	Rat
	PKN1 Antibody (YA1664) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PKN1.

HY-P81919A

	PKN1 Antibody (YA1664)(PBS only) DBK; PKN; pak1; PRK1; pak-1; PRKCL1; PKN-ALPHA	WB	Rat
	PKN1 Antibody (YA1664) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to PKN1.

HY-P84611A

	PKN1 Antibody (YA4308)(PBS only) DBK; PKN; pak1; PRK1; pak-1; PRKCL1; PKN-ALPHA	IHC-P, ICC/IF, FC, ELISA	Human
	PKN1 Antibody (YA4308) is a Mouse-derived and non-conjugated IgG2b monoclonal antibody, targeting to PKN1.

HY-P84612

	PRK2 Antibody (YA4309) PKN2; pak2; PRK2; pak-2; PRKCL2; PRO2042; MGC71074; MGC150606	WB, IHC-P, FC, ELISA	Human, Mouse, Rat, Monkey
	PRK2 Antibody (YA4309) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PRK2.

HY-P84612A

	PRK2 Antibody (YA4309)(PBS only) PKN2; pak2; PRK2; pak-2; PRKCL2; PRO2042; MGC71074; MGC150606	WB, IHC-P, FC, ELISA	Human, Mouse, Rat, Monkey
	PRK2 Antibody (YA4309) is a Mouse-derived and non-conjugated IgG1 monoclonal antibody, targeting to PRK2.

HY-P87646

	*phospho-PAK4/5/6 (Ser474/Ser602/Ser560) Antibody (YA7330)*	WB, FC	Human
	phospho-PAK4/5/6 (Ser474/Ser602/Ser560) Antibody (YA7330) is a Rabbit-derived and non-conjugated IgG monoclonal antibody, targeting to phospho-PAK4/5/6 (Ser474/Ser602/Ser560).